Patents by Inventor John E. McEntire

John E. McEntire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4405601
    Abstract: A biologically active lymphokine fraction which exhibits macrophage activation activity and lymphotoxin activity is prepared from large scale supernatant culture fluids of human lymphoblastoid cultured cell lines grown in the presence of human serum to minimize antigenicity. Growth of lymphoblastoid cells from human lymphoblastoid cultured cell lines is effected and the supernatant culture fluids are harvested, concentrated and clarified. The supernatant culture fluids are then extracted with trichloroacetic acid, guanidine hydrochloride, sodium dodecyl sulfate or perchloric acid as the extracting solvent followed by removal of the solvent. Further purification of the lymphokine fraction can be achieved by treatment with guanidine hydrochloride or sodium dodecyl sulfate as a dissociating solvent and by subjecting the lymphokine fraction to gel filtration, sodium dodecyl sulfate gel electrophoresis and/or high pressure liquid chromatography.
    Type: Grant
    Filed: May 21, 1981
    Date of Patent: September 20, 1983
    Assignee: Cancer Research Center
    Inventors: John E. McEntire, Ben W. Papermaster